Search PubMed⌕ Search

Biomedical subjects

T Teshima

Publications and source records attributed to T Teshima.

At least 289 records · Page 16Linked to original sources
PubMed1976

Indication of mediastinal lymph nodes metastases by radioaerosol inhalation lung scanning in pulmonary neoplasm.

Fifty-three patients with pulmonary neoplasm were studied by radioaerosol inhalation and perfusion lung scans, bronchoscopy and spirometry. The probability of lymph node metastases could be estimated by the amount of inhaled aerosol deposited at the carina. On thoracotomy, actual mediastinal lymphadenopathy was minimum, if any, in 4 patients without carinal aerosol deposition. Application of the aerosol inhalation lung scan to pulmonary neoplasm provides useful diagnostic and prognostic information regarding mediastinal lymph nodes metastases.

Adult↗
PubMedDate not supplied

Gallbladder opacification 12-24 h after angiography by CT examination: a multivariate analysis.

BACKGROUND: To examine the incidence and predisposing factors of gallbladder opacification in delayed computed tomography (CT) after angiography. METHODS: CT examination 12-24 h after angiography was performed in 389 patients. Univariate and multivariate analyses were made. RESULTS: Two hundred thirty-three of 389 patients (60%) revealed gallbladder opacification. Type of contrast medium (P < 0. 01), total bilirubin (P < 0.01), and serum creatinine (P < 0.01) were significant and independent factors relating to gallbladder opacification. Ioxaglate (70%, relative odds = 2.86) and iohexol (63%, relative odds = 2.03) showed higher gallbladder opacification rates than that of iopamidol (45%, relative odds = 1.43) and diatrizoate (30%). Patients with a lower serum bilirubin level (relative odds = 1.67) and a raised serum creatinine level (relative odds = 2.01) showed higher incidence of gallbladder opacification. CONCLUSION: Gallbladder opacification after angiography is not an abnormal finding on delayed CT in patients with not only abnormal renal function but also normal hepatobiliary and normal renal function, especially for modern contrast media.

Angiography↗
PubMedDate not supplied

Affinity purification of fusion chaperonin Cpn60-(His)(6) from thermophilic bacterium Bacillus strain MS and its use in facilitating protein refolding and preventing heat denaturation.

The cpn60 gene from Bacillus strain MS, which is highly homologous to Bacillus stearothermophilus, was cloned. Cpn60 with a hexahistidine affinity tag (His)(6) fused to its C-terminus (cpn60-(His)(6)) was overproduced in Escherichia coli. Cpn60-(His)(6) was expressed in a soluble form in E. coli. and purified to homogeneity in a single step by nickel chelate affinity chromatography. Cpn60-(His)(6) formed a tetradecamer and had ATPase activity. Cpn60-(His)(6) mediated refolding of guanidine hydrochloride unfolded pig heart malic dehydrogenase (MDH) and Thermus flavus MDH at 25 and 70 degrees C, respectively, in an ATP-dependent manner. In addition, cpn60-(His)(6) prevented heat denaturation of pig heart MDH and T. flavus MDH at 30 and 80 degrees C, respectively, in an ATP-dependent manner. Therefore, cpn60-(His)(6) facilitates protein refolding and prevents heat denaturation of proteins across a wide temperature range.

Bacillus↗
PubMedDate not supplied

Whole brain irradiation for metastases from lung carcinoma. A clinical investigation.

Sixty-nine consecutive patients with brain metastases from lung carcinoma were randomly allocated to one of two radiation therapy schedules: 30 Gy/10 fractions/2 weeks or 50 Gy/20 fractions/4 weeks. The improvement rate for neurologic function was similar in the two groups. The median survival times for patients receiving the short course and the long course were 4 months and 3 months, respectively. The half-year survival rate was 42 per cent after the short course and 14 per cent after the long course (p less than 0.05). Performance status and lactate dehydrogenase were other factors which significantly influenced the half-year survival rate.

Adenocarcinoma↗
PubMedDate not supplied

Automatic search for optimal conditions in clinical studies.

BACKGROUND: A program for an automatic search for the optimal conditions of important prognostic factors in clinical studies was developed. METHODS: The program was developed for the following steps: (1) Input of the maximum and minimum values and of the interval of the variable to be investigated. Automatic calculation of the Cut Points. (2) Division of the patient data into two groups at every Cut Point and calculation of survival rates. (3) Sequential calculation of P-values and chi-square values for the two sets of survival rates. To determine the usefulness of this program, the optimal irradiation dose was searched for 537 patients with non-small cell lung cancer. RESULTS: The P-value reached its minimum value and the chi-square value its maximum when the Cut Point was 5,925 cGy (0.0001 and 30.18). Between 5,925 cGy and 6,900 cGy, the P-value stayed at less than 0.05. CONCLUSION: Artificial errors in grouping by prognostic factors can be avoided and the search for optimal conditions can be conducted automatically and scientifically.

Automation↗
PubMedDate not supplied

Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck.

From October 1977 through September 1986, a total of 77 patients (Stage I, 26; II, 35; and III-IV, 16) with primary non-Hodgkin's lymphoma (NHL) of the head and neck were treated with radiation therapy and chemotherapy (CVP or CHOP regimen) or radiation therapy alone. Actuarial 5-year survival rates by stage were 79% in Stage I, 35% in II, and 8% in III-IV. Significant prognostic factors were clinical stage (p = 0.0001), histological grade by the Working Formulation (p = 0.0089), and surface marker (T and B cell analysis) (p = 0.0001). In Stage II patients, the serum lactate dehydrogenase (LDH) level (p = 0.0286), the number of cervical lymph nodes involved (p less than 0.03), and maintenance chemotherapy after initial treatment (p = 0.0077) were significant prognostic factors. In conclusion, more intensive chemoradiotherapy is necessary as the first-line treatment in those with poor prognosis, especially those with T-cell type and high grade histology. In addition, maintenance chemotherapy after initial chemoradiotherapy is very important for Stage II NHL patients, especially those with a high LDH value or multiple cervical lymph node involvement.

Antineoplastic Combined Chemotherapy Protocols↗
PubMedDate not supplied

Radiation therapy of the para-aortic lymph nodes in carcinoma of the uterine cervix: the concurrent use of cimetidine to reduce acute and subacute side effects from radiation.

A prospective study of the effects of radiation therapy (RT) on para-aortic lymph nodes in uterine cervical cancer was conducted. As part of the study, cimetidine (800 mg daily) was administered during RT to relieve and prevent adverse reactions of the gastrointestinal tract caused by RT. In half of the patients, cimetidine (400 mg daily) was continued after RT was finished. The RT field was 7 to 8 cm wide and covered the area from the 4th lumbar to 11th thoracic vertebrae. The total dose administered was 45 Gy in 25 fractions over a five-week period. From September 1986 through October 1987, 89 patients were entered in this study. During RT, only slight gastrointestinal symptoms, such as nausea, vomiting, appetite loss, fatigue, and epigastralgia, were observed. These symptoms increased when cimetidine was withdrawn, but not in the patients who continued to receive cimetidine. It is concluded that cimetidine during and after RT can reduce the acute and subacute side effects of RT.

Acute Disease↗
PubMedDate not supplied

Laser transmission photo-scanner: clinical application in breast tumor detection (report 3).

The increasing number of breast cancer patients in Japan necessitates the development of a useful screening method. Previous studies using a laser transmission photo-scanner for breast lesions showed its use to be feasible in screening for small lesions in small breasts. An increase in the power of the laser beam, however, is necessary to detect small tumors in larger breasts or large tumors. In cases where mammography was compared with laser transmission images, the latter were compatible with published data. More precise examination of laser transmission photo-scanning with the addition of spectro-analysis is the next step.

Breast Neoplasms↗
PubMedDate not supplied

Modified Inoue applicator for endometrial brachytherapy.

The Inoue applicator (3 channels) for endometrial cancer with a microSelectron-HDR was modified to enable both intrauterine and vaginal treatments to be done at the same time. The applicator is described together with a case report.

Adenocarcinoma↗
PubMedDate not supplied

Modified ovoid applicator for intracavitary radiation therapy with a Selectron-MDR or microSelectron-HDR.

A modified ovoid applicator for intracavitary radiotherapy was developed for Japanese and other Asian women. It has more variations of smaller sized ovoids than the original rigid standard applicator of the Selectron-MDR and microSelectron-HDR. In addition, application of the ovoid pair and tandem flange is easy due to the flat surface of the inner aspect of the ovoid pairs, which prevents slippage of the ovoids and flange. The applicator is described together with source loading and dose distribution.

Asia↗
PubMedDate not supplied

High-dose rate intracavitary therapy for cervical cancer with a microSelectron: a preliminary report.

Our early experience using microSelectron HDR to treat cervical cancer patients at Osaka University Hospital is presented. From June 1991 through December 1992, a total of 20 patients (stage Ib, 6; stage IIa, 2; stage IIb, 5; stage IIIb, 6 and stage IVa, 1) with previously untreated invasive uterine cervical cancer and intact uterus were treated with high-dose rate intracavitary therapy administered with a microSelectron. For the treatment, a standard rigid applicator made of stainless steel for a microSelectron was used. Twenty to 30 Gy of external irradiation was administered to the whole pelvic field and 30 to 20 Gy to the central shielded field (total 50 Gy/5-6 weeks) for patients in stage II-IVa. For stage Ib, 40 Gy was delivered to the central shielded field. The 192Ir source had an activity of 370 GBq as of the measuring time. Source loading corresponded to the Manchester System for cervical cancer. Thirty-two or 30 Gy was administered at point A in four fractions over four weeks of intracavitary irradiation. Early primary tumor responses for all patients were complete. There have been two local recurrences in stage IIb and IIIb patients. Three patients in stages Ib, IIb, and IIIb developed para-aortic lymph node metastases, and two of them died from generalized metastasis. No acute radiation injury has been observed. One patient in stage IIb developed subileus five months after irradiation. From our early experience, it is concluded that microSelectron HDR can be used for cervical cancer patients as safely and effectively as our previously used high-dose rate machine.

Brachytherapy↗